Sagimet Biosciences Inc. (SGMT) Operating income 2022–2025
Sagimet Biosciences Inc. (SGMT) annual operating income history from SEC filings — each fiscal year as reported.
-$56.9MFY2025 · since FY2022: -$31.1M → -$56.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$56.9M | -4.5% |
| FY2024 | -$54.5M | -77.1% |
| FY2023 | -$30.7M | +1.0% |
| FY2022 | -$31.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SGMT financial trends
SGMT RevenueSGMT Net incomeSGMT Net marginSGMT Gross profitSGMT Gross marginSGMT Operating marginSGMT Operating cash flowSGMT Free cash flowSGMT Capital expendituresSGMT Return on equitySGMT Stock buybacksSGMT Dividends paidSGMT Total assetsSGMT Total liabilitiesSGMT Shareholders’ equitySGMT overview →